摘要 : Abstract Sofosbuvir‐ledipasvir (SOF/LDV) had been proved to achieve high sustained virologic response (SVR) rate for patients with hepatitis C virus (HCV) genotype 1 infection. As for patients with HCV genotype 2 (HCV‐2) infecti... 展开
作者 | Li‐Jen Chang Ming‐Tse Hsu Tsung‐Jung Tsai Chien‐Chung Fang Chang‐Chao Su Yu‐Ling Lin Yu‐Ming Feng Chi‐Yi Chen Po‐Yueh Chen Hsin‐Yi Yang Chu‐Kuang Chou |
---|---|
作者单位 | |
期刊名称 | 《Advances in Digestive Medicine》 |
总页数 | 7 |
语种/中图分类号 | 英语 / R57 |
关键词 | effectiveness HCV genotype 2 ledipasvir sofosbuvir |
馆藏号 | N2014103000211773 |